Baidu
map

2020 多协会共识指南:胆囊切除术中胆管损伤的预防

2020-07-10 美国胃肠内镜外科医师学会 Surg Endosc . 2020 Jul;34(7):2827-2855.

美国胃肠与内镜外科医师协会(SAGES)为努力提高胆囊切除安全性和降低胆管损伤发生率,联合美国肝胆胰协会、国际肝胆胰协会、消化道外科协会和欧洲内镜外科协会就18个胆囊切除术胆管损伤相关的关键问题进行了

中文标题:

2020 多协会共识指南:胆囊切除术中胆管损伤的预防

英文标题:

Safe cholecystectomy multi-society practice guideline and state-of-the-art consensus conference on prevention of bile duct injury during cholecystectomy

发布日期:

2020-07-10

简要介绍:

美国胃肠与内镜外科医师协会(SAGES)为努力提高胆囊切除安全性和降低胆管损伤发生率,联合美国肝胆胰协会、国际肝胆胰协会、消化道外科协会和欧洲内镜外科协会就18个胆囊切除术胆管损伤相关的关键问题进行了全面的文献回顾,最终形成胆囊切除术中胆管损伤的预防多学会共识指南。

指南明确了胆囊切除术中避免胆管损伤的最佳方法,制定和推广基于循证医学证据的提高胆囊切除安全性的实践推荐意见,面向普外科医生、肝胆外科医生和实习医生,涵盖解剖辨识技巧、发病因素、操作技巧、医生培训和术中损伤处理等多项共识。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 多协会共识指南:胆囊切除术中胆管损伤的预防.pdf)] GetToolGuiderByIdResponse(projectId=1, id=949c01c002030e9b, title=2020 多协会共识指南:胆囊切除术中胆管损伤的预防, enTitle=Safe cholecystectomy multi-society practice guideline and state-of-the-art consensus conference on prevention of bile duct injury during cholecystectomy, guiderFrom=Surg Endosc . 2020 Jul;34(7):2827-2855., authorId=0, author=, summary=美国胃肠与内镜外科医师协会(SAGES)为努力提高胆囊切除安全性和降低胆管损伤发生率,联合美国肝胆胰协会、国际肝胆胰协会、消化道外科协会和欧洲内镜外科协会就18个胆囊切除术胆管损伤相关的关键问题进行了, cover=https://img.medsci.cn/20201227/1609073073784_2020535.jpg, journalId=0, articlesId=null, associationId=350, associationName=美国胃肠内镜外科医师学会, associationIntro=美国胃肠内镜外科医师学会是一个拥有超过5,000名会员的专业医学组织,主要致力于提供专业的胃肠内镜手术指导、教育、科研以及创新来优化病人的治疗与护理。, copyright=0, guiderPublishedTime=Fri Jul 10 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">美国胃肠与内镜外科医师协会(SAGES)为努力提高胆囊切除安全性和降低胆管损伤发生率,联合美国肝胆胰协会、国际肝胆胰协会、消化道外科协会和欧洲内镜外科协会就18个胆囊切除术胆管损伤相关的关键问题进行了全面的文献回顾,最终形成胆囊切除术中胆管损伤的预防多学会共识指南。</p> <p style="color: #373737;">指南明确了胆囊切除术中避免胆管损伤的最佳方法,制定和推广基于循证医学证据的提高胆囊切除安全性的实践推荐意见,面向普外科医生、肝胆外科医生和实习医生,涵盖解剖辨识技巧、发病因素、操作技巧、医生培训和术中损伤处理等多项共识。</p>, tagList=[TagDto(tagId=9899, tagName=胆囊切除术)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=9899, guiderKeyword=胆囊切除术, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2653, appHits=176, showAppHits=0, pcHits=781, showPcHits=2477, likes=5, shares=10, comments=11, approvalStatus=1, publishedTime=Sun Dec 27 22:03:53 CST 2020, publishedTimeString=2020-07-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 27 20:44:40 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:51:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 多协会共识指南:胆囊切除术中胆管损伤的预防.pdf)])
2020 多协会共识指南:胆囊切除术中胆管损伤的预防.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1067797, encodeId=5d26106e79774, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00a2800861, createdName=dghjyylj, createdTime=Sun Nov 07 14:32:37 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946723, encodeId=c0cc946e233e, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Tue Mar 09 10:56:46 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943888, encodeId=3545943888b3, content=优秀的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Sat Feb 27 08:15:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919596, encodeId=e3c191959603, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:12:10 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919491, encodeId=9d919194919d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddf41507565, createdName=zhaowenw, createdTime=Sun Jan 24 17:31:16 CST 2021, time=2021-01-24, status=1, ipAttribution=)]
    2021-11-07 dghjyylj

    实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1067797, encodeId=5d26106e79774, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00a2800861, createdName=dghjyylj, createdTime=Sun Nov 07 14:32:37 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946723, encodeId=c0cc946e233e, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Tue Mar 09 10:56:46 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943888, encodeId=3545943888b3, content=优秀的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Sat Feb 27 08:15:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919596, encodeId=e3c191959603, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:12:10 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919491, encodeId=9d919194919d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddf41507565, createdName=zhaowenw, createdTime=Sun Jan 24 17:31:16 CST 2021, time=2021-01-24, status=1, ipAttribution=)]
    2021-03-09 a6806376

    厉害

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1067797, encodeId=5d26106e79774, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00a2800861, createdName=dghjyylj, createdTime=Sun Nov 07 14:32:37 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946723, encodeId=c0cc946e233e, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Tue Mar 09 10:56:46 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943888, encodeId=3545943888b3, content=优秀的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Sat Feb 27 08:15:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919596, encodeId=e3c191959603, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:12:10 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919491, encodeId=9d919194919d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddf41507565, createdName=zhaowenw, createdTime=Sun Jan 24 17:31:16 CST 2021, time=2021-01-24, status=1, ipAttribution=)]
    2021-02-27 146f2fadm18暂无昵称

    优秀的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1067797, encodeId=5d26106e79774, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00a2800861, createdName=dghjyylj, createdTime=Sun Nov 07 14:32:37 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946723, encodeId=c0cc946e233e, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Tue Mar 09 10:56:46 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943888, encodeId=3545943888b3, content=优秀的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Sat Feb 27 08:15:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919596, encodeId=e3c191959603, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:12:10 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919491, encodeId=9d919194919d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddf41507565, createdName=zhaowenw, createdTime=Sun Jan 24 17:31:16 CST 2021, time=2021-01-24, status=1, ipAttribution=)]
    2021-01-25 浩浩0312

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1067797, encodeId=5d26106e79774, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00a2800861, createdName=dghjyylj, createdTime=Sun Nov 07 14:32:37 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946723, encodeId=c0cc946e233e, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Tue Mar 09 10:56:46 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943888, encodeId=3545943888b3, content=优秀的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Sat Feb 27 08:15:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919596, encodeId=e3c191959603, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:12:10 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919491, encodeId=9d919194919d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddf41507565, createdName=zhaowenw, createdTime=Sun Jan 24 17:31:16 CST 2021, time=2021-01-24, status=1, ipAttribution=)]
    2021-01-24 zhaowenw

    0

Baidu
map
Baidu
map
Baidu
map